Real-World Data / Real-Word Evidence Resources

41. Real-World Data Vs. Real-World Evidence 5/11/2023

    Unearth the ways real-world data (RWD) and real-world evidence (RWE) in clinical R&D can be used to provide additional validation for new therapies and drugs regarding their efficacy, safety, and value.

42. Modern Data Platform Strategies That Accelerate Clinical Development 11/26/2025

    A modern data platform is essential for clinical research because it unifies fragmented data, embeds governance, and enables faster, more reliable decision-making.

43. Comprehensive Data Management For Non-Interventional Research 4/8/2024

    Learn how your teams can embrace end-to-end clinical trial data platforms for non-interventional studies to improve user experience, boost patient engagement, ensure data quality, and achieve study success.

44. Reframing Vendor Selection: Beyond Price And Past Relationships 10/21/2025

    An RFP is more than a budget tool — it’s a strategic communication document that guides vendors, clarifies expectations, and enables informed, data-driven sponsor decisions.

45. The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials 10/21/2025

    Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.

46. Choosing An EDC With A Robust API For DTx Clinical Trials 4/20/2022

    This white paper explores the importance of choosing an EDC with an API before starting a clinical trial.

47. Simplifying The Data Journey From EHR To EDC 2/29/2024

    Explore how open API architecture represents a significant advancement in the integration of EHR and EDC systems, enhancing the potential of EHR data for clinical research.

48. Combining Patient-Centric Technology and RWD For Comprehensive Evidence 8/10/2022

    Explore how by combining digital technologies with secondary RWD, researchers can gather a more holistic understanding of the patient. 

49. Real-World Evidence - Where Are We Now? 8/24/2022

    Notwithstanding ongoing confusion over the concepts of “real-world data” and “real-world evidence” in 2022, more than 5 years after the passage of the 21st Century Cures Act, the FDA continues to evaluate such data and evidence as it considers regulatory decisions.

50. How To Reduce Risk And Effort When Migrating A TMF 10/19/2023

    Utilize this summary of key tips, checklists, and lessons learned to mitigate the risks and efforts associated with migrating a trial master file.